Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|December 28, 2016
Synchronous occurrence of squamous-cell carcinoma "transformation" and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinomaLucia Longo, Maria Cecilia Mengoli, Federica Bertolini, et al.Endocrine Pathology|September 4, 2010
Clear cell carcinoid of the appendix: an uncommon variant of lipid-rich neuroendocrine tumor with a broad differential diagnosisGiulio Rossi, Nazarena Nannini, Federica Bertolini, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive casesGiulio Rossi, Alessandro Marchioni, Elena Romagnani, et al.Journal of Hematology & Oncology|August 8, 2009
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case reportNorma Malavasi, Giovanni Ponti, Roberta Depenni, et al.Critical Reviews in Oncology/Hematology|January 10, 2020
Treating cancer with immunotherapy in HIV-positive patients: A challenging realityGiorgia Guaitoli, Cinzia Baldessari, Michela Maur, et al.Critical Reviews in Oncology/Hematology|February 28, 2018
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectivesChiara Tomasello, Cinzia Baldessari, Martina Napolitano, et al.Tumori|July 5, 2003
Preoperative concomitant radiotherapy and chemotherapy in ultrasound-staged T3 and T4 rectal cancerGabriele Luppi, Mario Santantonio, Federica Bertolini, et al.American Journal of Clinical Pathology|November 12, 2003
Does mesoappendix infiltration predict a worse prognosis in incidental neuroendocrine tumors of the appendix? A clinicopathologic and immunohistochemical study of 15 casesGiulio Rossi, Riccardo Valli, Federica Bertolini, et al.Immunotherapy|November 30, 2020
Pembrolizumab rechallenge in squamous non-small-cell lung cancer and HIV-positivity: a case reportGiorgia Guaitoli, Fausto Barbieri, Monica Barbolini, et al.Thoracic Cancer|April 7, 2017
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic casesMaria C Mengoli, Giulia Orsi, Filippo Lococo, et al.Pageof 10